Your browser doesn't support javascript.
loading
A Meta-analysis of Randomized Controlled Trials of the Effect of Probiotic Food or Supplement on Glycemic Response and Body Mass Index in Patients with Type 2 Diabetes, Updating the Evidence.
Jafarabadi, Mohammad Asghari; Dehghani, Azadeh; Khalili, Leila; Barzegar, Ali; Mesrizad, Mahdi; Hassanalilou, Tohid.
Afiliação
  • Jafarabadi MA; Department of statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Dehghani A; Department of Community Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Khalili L; Department of Community Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Barzegar A; Department of Community Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mesrizad M; Department of Nutrition, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hassanalilou T; Department of Nutrition, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Curr Diabetes Rev ; 17(3): 356-364, 2021.
Article em En | MEDLINE | ID: mdl-32787763
ABSTRACT

BACKGROUND:

To investigate the effects of probiotics on glucose metabolism and body mass index (BMI), and compare the efficacy of probiotic food with the probiotic supplement in patients with type 2 diabetes mellitus using a meta-analysis of randomized, controlled trials.

METHODS:

Online databases Embase, Web of Science, and PubMed were searched until November 2019 to identify eligible articles. Fourteen trials were included.

RESULTS:

Probiotic consumption reduced fasting plasma glucose (FPG) (SMD=-0.38, 95% CI -0.76 to 0.01), glycosylated hemoglobin (HbA1c) (SMD=-0.64, 95% CI -0.91 to -0.38), fasting insulin concentration (SMD=-0.48, 95% CI, -0.81 to -0.15), HOMA-IR (SMD=-1.01, 95% CI, -1.51 to -0.52), and BMI (SMD=-0.02, 95%CI, -0.17 to 0.13) in intervention groups compared with control groups. Subgroup analysis was conducted to trials with probiotic foods and probiotic supplements. Both of probiotic foods (SMD -0.65, 95% CI -1.04 to -0.26; SMD -1.17, 95% CI -2.14 to -0.20, respectively) and supplements (SMD -0.64, 95% CI -1.01 to -0.27; SMD -0.98, 95% CI -1.55 to -0.40, respectively) made significant reduction in HbA1c and HOMA.IR. Meta-analysis of trials with probiotic foods found non-significant changes in FBG and fasting insulin concentration (SMD 0.11, 95% CI -0.52 to 0.75; SMD -0.14, 95% CI -0.48 to 0.20, respectively); however the changes in trials with probiotic supplements were significant (SMD -0.73, 95% CI -1.22 to -0.23; SMD -0.57, 95% CI -0.97 to -0.17, respectively). Probiotic foods cause a non-significant raise in BMI (SMD 0.23, 95% CI -0.03 to 0.49); however, meta-analysis of trials with probiotic supplements found a non-significant reduction in BMI (SMD -0.13, 95% CI -0.31 to 0.04).

CONCLUSION:

The present meta-analysis suggests that consuming probiotics could improve glucose metabolism and affect body weight, with a potentially greater effect when probiotics are used as supplements.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Probióticos / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Probióticos / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2021 Tipo de documento: Article